-
Advances in Respiratory Medicine 2017
Topics: Contraceptive Devices, Female; Diaphragm; Female; Humans; Respiration; Tidal Volume
PubMed: 29083025
DOI: 10.5603/ARM.a2017.0047 -
Health Education Bulletin Aug 1980
Topics: Ambulatory Care Facilities; Contraception; Contraceptive Devices, Female; Counseling; Evaluation Studies as Topic; Family Planning Services; Health Planning; Organization and Administration
PubMed: 12278459
DOI: No ID Found -
Sexually Transmitted Diseases Jun 2010Female sex workers (n = 140) were enrolled in a 6-month acceptability trial of the diaphragm. We randomized a subset (n = 40) to receive colposcopies after 1 month of... (Randomized Controlled Trial)
Randomized Controlled Trial
Female sex workers (n = 140) were enrolled in a 6-month acceptability trial of the diaphragm. We randomized a subset (n = 40) to receive colposcopies after 1 month of diaphragm use or after 1 month of observation before commencing diaphragm use. Adverse events were mild in nature. Frequency of colposcopic findings did not differ between women randomized to immediate versus delayed diaphragm use (P = 0.25).
Topics: Adult; Colposcopy; Contraceptive Devices, Female; Female; HIV Infections; Humans; Sex Work; Sexual Behavior; Sexually Transmitted Diseases; Treatment Outcome
PubMed: 20473244
DOI: 10.1097/OLQ.0b013e3181ce147c -
The Journal of Urology Nov 1957
Topics: Catheterization; Catheters; Contraceptive Devices, Female; Female; Fistula; Humans; Urination Disorders; Vesicovaginal Fistula
PubMed: 13476544
DOI: 10.1016/S0022-5347(17)66491-7 -
Soins; La Revue de Reference Infirmiere Apr 1980
Topics: Contraception; Contraceptive Devices, Female; Contraceptive Devices, Male; Female; Humans; Intrauterine Devices; Male
PubMed: 6900388
DOI: No ID Found -
PloS One 2015Though South Africa has high contraceptive use, unintended pregnancies are still widespread. The SILCS diaphragm could reduce the number of women with unmet need by...
BACKGROUND
Though South Africa has high contraceptive use, unintended pregnancies are still widespread. The SILCS diaphragm could reduce the number of women with unmet need by introducing a discreet, woman-initiated, non-hormonal barrier method to the contraceptive method mix.
METHODS
A decision model was built to estimate the impact and cost-effectiveness of the introduction of the SILCS diaphragm in Gauteng among women with unmet need for contraception in terms of unintended and mistimed pregnancies averted, assuming that the available contraceptives on the market were not a satisfying option for those women. Full costs were estimated both from a provider's and user's perspective, which also accounts for women's travel and opportunity cost of time, assuming a 5% uptake among women with unmet contraceptive need. The incremental cost-effectiveness ratio is computed at five and 10 years after introduction to allow for a distribution of fixed costs over time. A probabilistic sensitivity analysis was conducted to incorporate decision uncertainty.
RESULTS
The introduction of the SILCS diaphragm in Gauteng could prevent an estimated 8,365 unintended pregnancies and 2,117 abortions over five years, at an annual estimated cost of US$55 per woman. This comes to a cost per pregnancy averted of US$153 and US$171 from a user's and provider's perspectives, respectively, with slightly lower unit costs at 10 years. Major cost drivers will be the price of the SILCS diaphragm and the contraceptive gel, given their large contribution to total costs (around 60%).
CONCLUSIONS
The introduction of the SILCS diaphragm in the public sector is likely to provide protection for some women for whom current contraceptive technologies are not an option. However to realize its potential, targeting will be needed to reach women with unmet need and those with likely high adherence. Further analyses are needed among potential users to optimize the introduction strategy.
Topics: Adolescent; Adult; Contraception; Contraception Behavior; Contraceptive Devices, Female; Cost-Benefit Analysis; Family Planning Services; Female; Health Services Accessibility; Humans; Middle Aged; Pregnancy; Pregnancy, Unplanned; South Africa
PubMed: 26295955
DOI: 10.1371/journal.pone.0134510 -
Contraceptive Technology Update Nov 1984
Topics: Ambulatory Care Facilities; Contraception; Contraceptive Devices, Female; Counseling; Family Planning Services; Health Planning; Organization and Administration
PubMed: 12313252
DOI: No ID Found -
Contraception Report Sep 1994
Topics: Contraception; Contraception Behavior; Contraceptive Devices, Female; Family Planning Services; Teaching Materials; Therapeutics
PubMed: 12345630
DOI: No ID Found -
Clinical Obstetrics and Gynecology Jun 1989
Review
Topics: Contraceptive Devices, Female; Contraceptive Devices, Male; Female; Humans; Male; Sexually Transmitted Diseases; Spermatocidal Agents
PubMed: 2663278
DOI: 10.1097/00003081-198906000-00022 -
La Revue Du Praticien Jan 2008Excluded hormonal contraceptives, there are non hormonal means of contraception. Among them, copper intrauterine devices (IUD) are very efficient. Copper IUD are the... (Review)
Review
Excluded hormonal contraceptives, there are non hormonal means of contraception. Among them, copper intrauterine devices (IUD) are very efficient. Copper IUD are the most used contraceptives in France and in the world, even then "false ideas", like contraindication to non steroidal anti-inflammatory drugs or higher risk of tubal infertility, have tarnished its reputation. The other non hormonal contraceptives, less effectiveness, include first, the male and female condoms which are the only efficient means to prevent sexually transmitted infections and then the "local" contraceptives like spermicides, diaphragms and cervical caps. The effectiveness of these methods depends primarily on their correct use (which requires a careful training). Then these "local" means are acceptable contraceptive methods only for specific use or for very motivated women.
Topics: Condoms; Condoms, Female; Contraception; Contraceptive Agents; Contraceptive Devices, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Male; Risk Assessment
PubMed: 18326359
DOI: No ID Found